Q1 2022 13F Holders as of 31 Mar 2022
-
Type / Class
-
Equity / American Depositary Shares, each representing one ordinary share
-
Shares outstanding
-
40,291,821
-
Total 13F shares
-
4,627,371
-
Share change
-
-274,221
-
Total reported value
-
$23,843,000
-
Price per share
-
$5.20
-
Number of holders
-
10
-
Value change
-
-$1,912,073
-
Number of buys
-
2
-
Number of sells
-
8
Institutional Holders of Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) as of Q1 2022
As of 31 Mar 2022,
Barinthus Biotherapeutics plc. - American Depositary Shares, each representing one ordinary share (BRNS) was held by
10 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
4,627,371 shares.
The largest 10 holders included
Alphabet Inc., M&G INVESTMENT MANAGEMENT LTD, DC Funds, LP, Liontrust Investment Partners LLP, BlueCrest Capital Management Ltd, Johns Hopkins University, MILLENNIUM MANAGEMENT LLC, Ipswich Investment Management Co., Inc., MORGAN STANLEY, and UBS Group AG.
This page lists
10
institutional shareholders reporting positions in this security
for the Q1 2022 filing period.
| Investor |
Option |
Weight % |
Change % |
Value $ |
* Price
|
Shares |
Share Change |
Activity |
Report Period |
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.